UpdatesPress Release
Gland Pharma delivered record Q1FY27 revenue of ₹1,800.3 Cr (+20% YoY) and PAT of ₹317 Cr (+47% YoY). Growth driven by successful CDMO strategy, new product launches, and robust B2B demand.
Gland Pharma LimitedGLAND · Filed with the exchange
Strong pipeline and new partnerships underpin future expansion.
No comments yet. Be the first.